Skip to main content

MI Judge Refuses To Dismiss A Biomet Hip Replacement Case

MI Judge Refuses To Dismiss A Biomet Hip Replacement Case

MI Judge Refuses To Dismiss A Biomet Hip Replacement Case

Introduction

Last week, Judge Hala Y. Jarbou of the U.S. District Court for the Western District of Michigan denied dismissing a lawsuit brought by a woman against Biomet Orthopedics LLC over its allegedly defective hip implant on the grounds that the claim was not time-barred.

The lawsuit, filed in 2016, stated that the plaintiff received the implant in 2006 and started suffering from pain in 2012. The suit noted that initially, the pain began in her right quad, which later shifted over to the hip by 2014. The plaintiff went to a doctor who referred her to a physical therapist.

The therapist believed the reason for causing the pain was implant surgery, which might have weakened the plaintiff's tendons and muscles, and there were no other clear causes, such as a recent fall. The plaintiff underwent revision surgery in 2014 and removed the implants.

In the November 2 opinion, the judge indicated she did not find the claim for fraudulent misrepresentation time-barred, rejecting Biomet's argument that the lawsuit was filed after Michigan's three-year statute of limitations. The opinion also noted that the plaintiff's blood samples showed slightly elevated levels of cobalt and chromium, indicating issues with the implant.

The judge stated that "in light of multiple potential causes, there is a genuine dispute as to when the implant allegedly began to inflict pain on the plaintiff. In other words, a reasonable juror could find that the hip implant did not harm the plaintiff before July 14, 2013, if they found the implant defective at all."

The lawsuit alleges the manufacturer knew for more than five years that its M2A-Magnum Hip Replacement System is likely to fail earlier than expected, and the metal ball and socket bearings have a tendency to release metal debris through wear and tear.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!